Sleep Aids - Eastern Asia

  • Eastern Asia
  • In 2024, the revenue in the Sleep Aids market market in Eastern Asia amounts to US$0.66bn.
  • It is projected to experience an annual growth rate of 6.87% (CAGR 2024-2029).
  • When compared globally, the in the United States generates the highest revenue in this market, with US$2,103.00m in 2024.
  • Taking into account the population figures, the per person revenue in Eastern Asia is US$0.40 in 2024.
  • In Eastern Asia, the market for sleep aids is experiencing a surge in demand due to the high-stress lifestyle prevalent in countries like Japan and South Korea.

Key regions: Australia, China, United Kingdom, Canada, United States

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Sleep Aids market in Eastern Asia has been experiencing significant growth in recent years. Customer preferences for sleep aids in Eastern Asia have been influenced by several factors. One major factor is the increasing prevalence of sleep disorders in the region. As the pace of life becomes faster and more stressful, many people in Eastern Asia are finding it difficult to get a good night's sleep. This has led to a growing demand for sleep aids that can help improve sleep quality and duration.Another customer preference in the Sleep Aids market in Eastern Asia is the preference for natural and herbal remedies. Many consumers in the region are becoming more health-conscious and are looking for sleep aids that are made from natural ingredients. This trend is driven by a desire to avoid the potential side effects of synthetic sleep aids and to adopt a more holistic approach to health and wellness.In addition to these customer preferences, there are several trends in the Sleep Aids market in Eastern Asia. One trend is the increasing availability and awareness of sleep aids. As the market grows, more companies are entering the market and offering a wide range of sleep aids to cater to different customer needs. This increased competition has led to greater product innovation and improved quality.Another trend in the Sleep Aids market in Eastern Asia is the growing popularity of online sales channels. Many consumers in the region are now purchasing sleep aids online, as it offers convenience and a wider selection of products. This shift towards online sales has also allowed smaller, niche sleep aid brands to reach a larger customer base.Local special circumstances in the Sleep Aids market in Eastern Asia also play a role in its development. One special circumstance is the cultural significance of sleep in the region. In many Eastern Asian cultures, sleep is considered a vital part of maintaining good health and well-being. This cultural emphasis on sleep has contributed to the growing demand for sleep aids in the region.Underlying macroeconomic factors have also contributed to the growth of the Sleep Aids market in Eastern Asia. Economic growth and rising disposable incomes in countries like China, Japan, and South Korea have increased consumer spending power. As a result, more people in the region are able to afford sleep aids and are willing to invest in products that can improve their sleep quality.In conclusion, the Sleep Aids market in Eastern Asia is experiencing growth due to customer preferences for sleep aids that can improve sleep quality, the increasing availability and awareness of sleep aids, the growing popularity of online sales channels, the cultural significance of sleep, and underlying macroeconomic factors such as economic growth and rising disposable incomes.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)